Evolving pharmaceutical therapies for confronting COVID-19: An overview

R Ghai, K Nagarajan, T Mishra, S Vats… - AIP Conference …, 2022 - pubs.aip.org
December 2019 was marked by the arrival of the novel coronavirus, which has now
reportedly resulted in 4,200,412 deaths (as ofJuly 30, 2021) world-wide. Although the …

Hot Topic Commentary on COVID-19

AN Kong, ATY Lau, L Brunetti - Current pharmacology reports, 2020 - Springer
The recent pandemic outbreak of COVID-19 (severe acute respiratory syndrome coronavirus
2; SARS-CoV-2) worldwide caught the health care systems in every country around the …

Current scenario and future prospect in the management of COVID-19

P Borah, PK Deb, S Deka… - Current Medicinal …, 2021 - ingentaconnect.com
The COVID-19 pandemic continues to wreak havoc worldwide due to the lack of risk
assessment, rapid spreading ability, and propensity to precipitate severe disease in …

COVID-19: A review of the proposed pharmacological treatments

S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …

A Therapeutic Journey of Potential Drugs Against COVID-19

F Ali, S Hussain, YZ Zhu - Mini Reviews in Medicinal Chemistry, 2022 - ingentaconnect.com
Coronavirus disease (CoVID-19) caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) scrambles the world by infecting millions of peoples all over the globe. It …

[HTML][HTML] Current status of COVID-19 treatment: An opinion review

S Di Franco, A Alfieri, S Petrou, G Damiani… - World journal of …, 2020 - ncbi.nlm.nih.gov
The pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
has garnered the attention of scientists worldwide in the search for an effective treatment …

[HTML][HTML] Emerging therapeutics in the management of COVID-19

A Kichloo, M Albosta, A Kumar, M Aljadah… - World Journal of …, 2021 - ncbi.nlm.nih.gov
The severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019, COVID-
19) pandemic has placed a tremendous burden on healthcare systems globally …

[HTML][HTML] Emerging pharmaceutical treatments of novel COVID-19: a review

A Hussain, J Kaler, AK Dubey - Cureus, 2020 - ncbi.nlm.nih.gov
As a new decade began, COVID-19 quickly gained importance as it became the cause of
the current global pandemic. Research has been focusing on studying the structure of SARS …

Current challenges for the effective management of the COVID-19 pandemic

V Sinha, S Saxena, SK Pandey, S Dwivedi… - … Therapeutics–Volume II …, 2022 - Springer
Introduction: Within a short period, the coronavirus disease (COVID-19) caused by severe
acute respiratory syndrome coronavirus (SARS-CoV-2) spread all over the globe and …

A review: Divergent emerging strategies to tackle challenging covid-19

SU Puri, AA Bhimanwar, MM Vaidya - Journal of Drug Delivery and …, 2020 - jddtonline.info
Background: Contemplating the severity of pandemic sequel for public health many
researchers are working recklessly for new targeted drugs and vaccines. Despite the …